U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 518 records

Showing results for "resistance".

  1. Asthma-Treatment Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
    May 01, 2011 - than those without asthma.10 A reduction in end-tidal CO2 levels has been shown to increase airway resistance … bronchial hyperresponsiveness to histamine, but not in matched controls without asthma.11 Further, airway resistance … breath by prolonging the expiratory phase, enhancing abdominal/diaphragmatic breathing, and imposing resistance … Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects.

  2. Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research-protocol
    June 19, 2014 - Current Page Topic Timeline Mar. 11, 2013 Topic Suggestion Jun. 19, 2014 Research Protocol Dec. 8, 2015 Systematic Review May. 5, 2016 Disposition of Comments Report Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder Research Protocol Archived June 19, 2014 Downl…

  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
    January 01, 2007 - Layout 1 Background Aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone are atypical antipsychotics approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These drugs have been studied for off-label use in the following conditions: dementia and seve…

  4. PULMONARY with "Discussions" in Exec Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Some experts stated risk of hearing loss, cardiac arrhythmias, and antibiotic resistance are factors

  5. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
    January 01, 2011 - dialysis (i.e., peritoneal or hemodialysis)  Patient subgroups (i.e., age, sex, comorbid conditions, ESA resistance … subgroups, type of dialysis, different reference standards --: Dialysis type; patient subgroups; ESA resistance

  6. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - might be concerned about the potential for overprescribing antibiotics and an increase in microbial resistance … Since this changes the workflow, there would be resistance. … be apprehensive about utilizing antibiotics at increasing rates due to concerns about antibiotic resistance

  7. Hepatitis-C-Treatment-Adherence Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
    September 22, 2011 - interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance … Early viral response • Sustained viral response • Histological changes • Biochemical markers • Drug resistance … interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance

  8. Chronic-Kidney-Disease-Anemia-2011 Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
    January 01, 2011 - erythropoiesis; however, decreased iron stores or iron availability are the most common reasons for resistance … hemodialysis) • Patient subgroups (i.e., age, sex, comorbid conditions, erythropoiesis-stimulating agent resistance … Patient subgroups (i.e., age, sex, comorbid conditions, erythropoiesis-stimulating agent resistance

  9. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 08: Functional Limitations and Disability Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

  10. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
    October 01, 2016 - Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention Evidence Report/Technology Assessment Number 222 Data Linkage Strategies To Advance Youth Suicide Prevention Evidence-Based Practice Evidence Report/Technology Assessment Number 222 Data Linkage Strategies To Advance Y…

  11. Bacterial Infections | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/bacterial-infections/

  12. Microsoft Word - finbody.doc (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - Microsoft Word - finbody.doc This report is based on research conducted by the Tufts-New England Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions in this d…

  13. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - compromised in patients with AD. 33,34 Additionally, “peripheral insulin abnormalities” (e.g., insulin resistance … unclear whether the therapy will provide ongoing benefit or whether patients may develop insulin resistance

  14. Treatment for Bipolar Disorder | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
    June 23, 2014 - Outcomes by comorbidity and treatment resistance   Lithium Treatment Resistant Comorbid Substance

  15. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/deliberative-methods/research-2013-1
    November 01, 2013 - should be considered, potential tradeoffs in values, and potential solutions and their likely uptake or resistance

  16. First and Second Generation Antipsychotics for Children and Young Adults-Comparative Effectiveness Review Update | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/antipsychotics-children-update/research-protocol
    December 07, 2015 - metabolic syndrome, change in body composition [weight, BMI], fasting glucose, insulin sensitivity/resistance … = hemoglobin A1c; HDL = high-density lipoprotein; HOMA–IR = homeostasis model assessment of insulin resistance … cholesterol, LDL and HDL cholesterol, triglycerides, ratio of triglycerides to HDL cholesterol Insulin resistance

  17. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

  18. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

  19. McCormack-notes-151008 copy - Teresa (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/mccormack-presentation.pdf
    November 12, 2015 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…

  20. Diabetes-Drugs-Utilization Research (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
    March 01, 2011 - insulin in response to meals and peripheral tissues fail to properly respond to insulin (insulin resistance
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites